Thomas M Moriarty

CIK 1412221 · EVP, M&A and Corporate Affairs · last filed 2026-09-10

Thomas M Moriarty is an EVP, M&A and Corporate Affairs who has filed 77 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for ACI, was dated Sep 10, 2026. Across all open-market trades the lifetime net is −$73.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $48.6M across reported positions. 2 SEC filings were submitted jointly with CELGENE CORP /DE/.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$48.56M

Companies

Total Filings

Lifetime Open-Market Net

-$73.28M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

Filer Profile

Reported Address

100 PARSONS POND DRIVE
FRANKLIN LAKES, NJ 07417

Related Filers

CELGENE CORP /DE/ — 2 joint filings, latest 2012-06-05

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
ACI	EVP, M&A and Corporate Affairs	617,892	$11.60	$7.16M	$1.96M	27	2026-09-10
CVS	EVP & General Counsel	474,393	$87.27	$41.40M	-$66.46M	30	2023-01-04
CELGENE CORP /DE/ (CELGZ) Delisted	see remarks	—	—	—	$0	1	2012-06-05
MEDCO HEALTH SOLUTIONS INC (MHS) Delisted	Gen'l Counsel & Secretary, SVP	0	—	—	-$8.78M	19	2012-04-03

Recent Filings

77 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2026-09-10	ACI	Grant (A)	—	$0	EDGAR
2026-08-11	ACI	Grant (A)	—	$0	EDGAR
2026-07-28	ACI	Buy (P)	+170,500	$1.96M	EDGAR
2026-05-12	ACI	Grant (A)	—	$0	EDGAR
2026-04-23	ACI	Mixed	+44,691	$1.42M	EDGAR
2026-04-20	ACI	Mixed	—	$0	EDGAR
2026-04-09	ACI	Exer (M)	—	$0	EDGAR
2026-03-04	ACI	Mixed	+59,768	$1.07M	EDGAR
2026-02-10	ACI	Grant (A)	—	$0	EDGAR
2025-12-04	ACI	Exer (M)	—	$0	EDGAR

Showing 1–10 of 77

Page 1 of 8 Next

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.